| 000 | 00752namaa2200205#ar4500 | ||
|---|---|---|---|
| 001 | 021563 | ||
| 008 | 130822s2000 xxc f eng d | ||
| 020 | _a1-895561-84-1 (part 2) | ||
| 082 |
_a617.356 _bT258d1 _809 |
||
| 245 |
_aTechnology report : _bdrug treatments for alzheimer's disease. II. A review of outcome measures in clinical trials _cChristina Wolfson ...[et al.] |
||
| 260 |
_aOttawa, Can. : _bCCOHTA, _c2000. |
||
| 300 | _a137 p. | ||
| 490 |
_aTechnology report ; _n09 |
||
| 650 |
_aEnfermedad de Alzheimer _xPrevención y Control. |
||
| 700 |
_aMoride, Yola _ecoaut. |
||
| 700 |
_aPerrault, Anne _ecoaut. |
||
| 700 |
_aWolfson, Christina _ecoaut. |
||
| 710 | _aCanadian Coordinating Office for Health Technology Assessment | ||
| 942 | _cBK | ||
| 999 |
_c9980 _d9980 |
||